TORONTO, Jan. 5, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that Dr. Isa Odidi, CEO, will present a Company overview at the Biotech Showcase Conference in San Francisco at 11:30am PST on Wednesday, January 11, 2012.
